VivaBioCell. Delivering next-generation manufacturing solutions for sustainable cell therapies


cGMP-compliance, Scale Out and Cost Efficiency. Enabling the transition from your manual protocol to an automated process. Learn more ⟩


Empowering your ATMP manufacturing with Automation, Flexibility, Integrated Imaging and Remote Monitoring. Learn more ⟩

NANT XL System

The evolution of automated cell expansion systems for mid- up to large-scale batch sizes. Maximum flexibility in cell expansion for clinical and commercial Advanced Therapies manufacturing needs. Learn more ⟩

NANT XL System

NANT 001 System

Seamless transition from R&D to clinical and commercial manufacturing. Automated cell expansion for small- to mid-scale batches, ideal for autologous and redistributed scale-out manufacturing. Learn more ⟩

NANT 001 System

NANT Maestro

Your cell factory dashboard. A range of Apps to help you monitor and manage all your NANT Systems from one easy, centralized and convenient interface. Learn more ⟩

NANT Maestro

Latest News

GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor
The results of this GMP-validation study conducted at the Regenerative Medicine Institute (REMEDI) confirm the ability of NANT 001 System in conducting automated MSCs expansions, meeting all the GMP requirements in terms of safety, traceability and reproducibility in a cost-effective manner. Read more ⟩

ImmunityBio + NANT 001 Bioreactor

VivaBioCell is Gold Sponsor of Advanced Therapies Virtual Congress & Expo (London, 5-6 October 2021)
We're thrilled to confirm our participation at the next Advanced Therapies Congress & Expo (London, 5-6 October 2021) as GOLD sponsor of this international event. Read more ⟩

Webinar 2021

Join us for our new webinar on September 9th 2021 (3.00 pm - CET)
We are delighted to announce the free webinar "Overcoming the challenges of ATMP manufacturing with novel automated systems for cell expansion: Tackling GMP-compliance, scalability and cost efficiency" where we will discuss the challenges of cell therapy manufacturing and how VivaBioCell automated technology helps overcome them. Read more ⟩